Prophylactic human papilloma virus vaccines for cervical cancer may also prevent development of breast and oropharyngeal cancers in women
作者： Hakan Harputluoglu , Omer Dizdar , Kadri Altundag
DOI: 10.1016/J.MEHY.2006.03.024
关键词: Oropharyngeal Cancers 、 Cervical cancer 、 Cancer 、 Medicine 、 Oncology 、 Internal medicine 、 Human Papilloma Virus Vaccine
摘要:
elsevier.com
sci-hub.se 参考文章(3)
J Thomas Cox, The development of cervical cancer and its precursors: what is the role of human papillomavirus infection? Current Opinion in Obstetrics & Gynecology. ,vol. 18, ,(2006) , 10.1097/01.GCO.0000216315.72572.FB
Edward J Mayeaux, Harnessing the power of prevention: human papillomavirus vaccines. Current Opinion in Obstetrics & Gynecology. ,vol. 18, ,(2006) , 10.1097/01.GCO.0000216316.10690.C6
Ozden Altundag, Kadri Altundag, Paolo Morandi, Mehmet Gunduz, Adjuvant targeted therapy with trastuzumab may decrease metastatic capacity in specific group of oropharyngeal cancer patients: downregulation of E-cadherin-catenin complex by cooperative effect of erbB-2 and human papillomavirus type 16 E6/E7 protooncogenes. Medical Hypotheses. ,vol. 63, pp. 277- 280 ,(2004) , 10.1016/J.MEHY.2004.03.013